Quick Answer
CytoDyn Inc. reported Net Income Loss of $3.75 million for the year ending 2025.
- CytoDyn Inc. showed an increase of +107.5% in Net Income Loss from 2024 to 2025.
- This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on July 25, 2025.
- XBRL data for this metric is available from 2005 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: -$8.11 million | Q2 2017: -$6.83 million | Q3 2017: -$11.63 million | Q4 2017: -$10.95 million | Q1 2018: -$17.95 million | Q2 2018: -$9.62 million | Q3 2018: -$14.41 million | Q4 2018: -$14.31 million | Q1 2019: -$12.57 million | Q3 2019: -$16.16 million | Q4 2019: -$14.86 million | Q1 2020: -$35.77 million | Q3 2020: -$30.83 million | Q4 2020: -$37.98 million | Q1 2021: -$37.58 million | Q3 2021: -$45.34 million | Q4 2021: -$40.08 million | Q1 2022: -$41.29 million | Q3 2022: -$20.99 million | Q4 2022: -$26.50 million | Q1 2023: -$13.70 million | Q3 2023: -$11.57 million | Q4 2023: -$9.56 million | Q1 2024: -$11.92 million | Q3 2024: $19.23 million | Q4 2024: -$4.77 million | Q1 2025: -$4.76 million | Q3 2025: -$5.54 million | Q4 2025: -$22.61 million.
- Over the full 21 years of available data (2005 to 2025), CytoDyn Inc.'s Net Income Loss has grown by 581.9%.
- Historical annual values: Fiscal year 2025: $3.75 million | Fiscal year 2024: -$49.84 million | Fiscal year 2023: -$79.82 million | Fiscal year 2022: -$210.82 million | Fiscal year 2021: -$176.47 million | Fiscal year 2020: -$139.94 million | Fiscal year 2019: -$56.19 million | Fiscal year 2018: -$50.15 million | Fiscal year 2017: -$25.76 million | Fiscal year 2016: -$25.70 million | Fiscal year 2015: -$25.09 million | Fiscal year 2014: -$12.43 million | Fiscal year 2013: -$9.57 million | Fiscal year 2012: -$7.47 million | Fiscal year 2011: -$3.72 million | Fiscal year 2010: -$3.36 million | Fiscal year 2009: -$1.31 million | Fiscal year 2008: -$1.19 million | Fiscal year 2007: -$2.61 million | Fiscal year 2006: -$2.05 million | Fiscal year 2005: -$777.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: